{"id":"https://openalex.org/W2021908659","doi":"https://doi.org/10.1007/s10637-005-2903-3","title":"An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin","display_name":"An NCIC-CTG phase I dose escalation pharmacokinetic study of the matrix metalloproteinase inhibitor BAY 12-9566 in combination with doxorubicin","publication_year":2005,"publication_date":"2005-08-13","ids":{"openalex":"https://openalex.org/W2021908659","doi":"https://doi.org/10.1007/s10637-005-2903-3","mag":"2021908659","pmid":"https://pubmed.ncbi.nlm.nih.gov/16133795"},"language":"en","primary_location":{"id":"doi:10.1007/s10637-005-2903-3","doi":"https://doi.org/10.1007/s10637-005-2903-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-005-2903-3","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2021908659"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5026047065","display_name":"Hal W. Hirte","orcid":"https://orcid.org/0000-0003-2888-4146","observed_orcids":["https://orcid.org/0000-0003-2888-4146"]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"H. Hirte","raw_affiliation_strings":["Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada, L8V 5C2. Hal.Hirte@HRCC.ON.CA","Hamilton Regional Cancer Centre, Hamilton, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hamilton Regional Cancer Centre, Hamilton, Ontario, Canada, L8V 5C2. Hal.Hirte@HRCC.ON.CA","institution_ids":[]},{"raw_affiliation_string":"Hamilton Regional Cancer Centre, Hamilton, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5100609224","display_name":"David J. Stewart","orcid":"https://orcid.org/0000-0002-0184-7946","observed_orcids":["https://orcid.org/0000-0002-0184-7946"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"D. Stewart","raw_affiliation_strings":["Ottawa Regional Cancer Centre, Ottawa, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ottawa Regional Cancer Centre, Ottawa, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5012785119","display_name":"Rakesh Goel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Goel","raw_affiliation_strings":["Ottawa Regional Cancer Centre, Ottawa, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ottawa Regional Cancer Centre, Ottawa, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008312330","display_name":"Edmond Emilien Chouinard","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Chouinard","raw_affiliation_strings":["Hamilton Regional Cancer Centre, Hamilton, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hamilton Regional Cancer Centre, Hamilton, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090617731","display_name":"Susan D. Huan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Huan","raw_affiliation_strings":["Ottawa Regional Cancer Centre, Ottawa, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ottawa Regional Cancer Centre, Ottawa, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109145083","display_name":"S. Stafford","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Stafford","raw_affiliation_strings":["Hamilton Regional Cancer Centre, Hamilton, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hamilton Regional Cancer Centre, Hamilton, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043942525","display_name":"B. Waterfield","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Waterfield","raw_affiliation_strings":["Ottawa Regional Cancer Centre, Ottawa, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Ottawa Regional Cancer Centre, Ottawa, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103204298","display_name":"Sarah W. Matthews","orcid":"https://orcid.org/0000-0002-2840-642X","observed_orcids":["https://orcid.org/0000-0002-2840-642X"]},"institutions":[{"id":"https://openalex.org/I4405267856","display_name":"Canadian Cancer Trials Group","ror":"https://ror.org/04rg46g58","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4405267856"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"S. Matthews","raw_affiliation_strings":["National Cancer Institute of Canada\u2014Clinical Trials Group, Kingston, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute of Canada\u2014Clinical Trials Group, Kingston, Ontario","institution_ids":["https://openalex.org/I4405267856"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024245359","display_name":"Chetan D. Lathia","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Lathia","raw_affiliation_strings":["Bayer Inc., Etobicoke, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Inc., Etobicoke, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045588447","display_name":"Brian E. Schwartz","orcid":"https://orcid.org/0000-0003-2632-6351","observed_orcids":["https://orcid.org/0000-0003-2632-6351"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Schwartz","raw_affiliation_strings":["Bayer Inc., Etobicoke, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Inc., Etobicoke, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068661241","display_name":"Vipin Agarwal","orcid":"https://orcid.org/0000-0002-5061-4743","observed_orcids":["https://orcid.org/0000-0002-5061-4743"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"V. Agarwal","raw_affiliation_strings":["Bayer Inc., Etobicoke, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Inc., Etobicoke, Ontario","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5048698138","display_name":"Rachel W. Humphrey","orcid":"https://orcid.org/0009-0007-6425-675X","observed_orcids":["https://orcid.org/0009-0007-6425-675X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"R. Humphrey","raw_affiliation_strings":["Bayer Inc., Etobicoke, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bayer Inc., Etobicoke, Ontario","institution_ids":[]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023189232","display_name":"and L. Seymour","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405267856","display_name":"Canadian Cancer Trials Group","ror":"https://ror.org/04rg46g58","country_code":"CA","type":"nonprofit","lineage":["https://openalex.org/I4405267856"]}],"countries":["CA"],"is_corresponding":false,"raw_author_name":"and L. Seymour","raw_affiliation_strings":["National Cancer Institute of Canada\u2014Clinical Trials Group, Kingston, Ontario"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Cancer Institute of Canada\u2014Clinical Trials Group, Kingston, Ontario","institution_ids":["https://openalex.org/I4405267856"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5026047065"],"corresponding_institution_ids":[],"apc_list":{"value":4690,"currency":"USD","value_usd":4690},"apc_paid":null,"fwci":0.2314,"has_fulltext":false,"cited_by_count":7,"citation_normalized_percentile":{"value":0.5439787,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":93},"biblio":{"volume":"23","issue":"5","first_page":"437","last_page":"443"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10620","display_name":"Protease and Inhibitor Mechanisms","score":0.9487000107765198,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10375","display_name":"Pharmacogenetics and Drug Metabolism","score":0.00800000037997961,"subfield":{"id":"https://openalex.org/subfields/3004","display_name":"Pharmacology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11845","display_name":"Cancer therapeutics and mechanisms","score":0.003700000001117587,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/marimastat","display_name":"marimastat","score":0.8130000233650208},{"id":"https://openalex.org/keywords/matrix-metalloproteinase-inhibitors","display_name":"matrix metalloproteinase inhibitors","score":0.972000002861023},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":0.9980000257492065},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.7950000166893005},{"id":"https://openalex.org/keywords/advanced-solid-tumors","display_name":"advanced solid tumors","score":0.8339999914169312},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8539999723434448},{"id":"https://openalex.org/keywords/drug-interactions","display_name":"drug interactions","score":0.8019999861717224},{"id":"https://openalex.org/keywords/maximum-tolerated-dose","display_name":"maximum tolerated dose","score":0.953000009059906},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.8349999785423279},{"id":"https://openalex.org/keywords/stomatitis","display_name":"stomatitis","score":0.8500000238418579},{"id":"https://openalex.org/keywords/granulocytopenia","display_name":"granulocytopenia","score":0.9319999814033508},{"id":"https://openalex.org/keywords/thrombocytopenia","display_name":"thrombocytopenia","score":0.996999979019165}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7744204998016357},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7445192337036133},{"id":"https://openalex.org/C2781303535","wikidata":"https://www.wikidata.org/wiki/Q18936","display_name":"Doxorubicin","level":3,"score":0.7168456315994263},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.6529970169067383},{"id":"https://openalex.org/C2777288759","wikidata":"https://www.wikidata.org/wiki/Q4164182","display_name":"Dosing","level":2,"score":0.5083910822868347},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5071289539337158},{"id":"https://openalex.org/C29730261","wikidata":"https://www.wikidata.org/wiki/Q274160","display_name":"Toxicity","level":2,"score":0.4808231592178345},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.43401989340782166},{"id":"https://openalex.org/C2779051857","wikidata":"https://www.wikidata.org/wiki/Q911386","display_name":"Stomatitis","level":2,"score":0.4291744530200958},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.37419891357421875},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.22159454226493835}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000903","descriptor_name":"Antibiotics, Antineoplastic","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":true},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001713","descriptor_name":"Biphenyl Compounds","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D002277","descriptor_name":"Carcinoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D009930","descriptor_name":"Organic Chemicals","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D009930","descriptor_name":"Organic Chemicals","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D010654","descriptor_name":"Phenylbutyrates","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012509","descriptor_name":"Sarcoma","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019714","descriptor_name":"Tissue Inhibitor of Metalloproteinases","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D019714","descriptor_name":"Tissue Inhibitor of Metalloproteinases","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1007/s10637-005-2903-3","doi":"https://doi.org/10.1007/s10637-005-2903-3","is_oa":false,"landing_page_url":"https://doi.org/10.1007/s10637-005-2903-3","pdf_url":null,"source":{"id":"https://openalex.org/S6037287","display_name":"Investigational New Drugs","issn_l":"0167-6997","issn":["0167-6997","1573-0646"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1"],"host_organization":"https://openalex.org/P4310319900","host_organization_name":"Springer Science+Business Media","host_organization_lineage":["https://openalex.org/P4310319900","https://openalex.org/P4310319965"],"host_organization_lineage_names":["Springer Science+Business Media","Springer Nature"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational New Drugs","raw_type":"journal-article"},{"id":"pmid:16133795","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/16133795","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Investigational new drugs","raw_type":"Clinical Trial, Phase I"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":16,"referenced_works":["https://openalex.org/W1481220364","https://openalex.org/W1895946034","https://openalex.org/W1999784741","https://openalex.org/W2004239257","https://openalex.org/W2032116931","https://openalex.org/W2054234083","https://openalex.org/W2062227583","https://openalex.org/W2067215057","https://openalex.org/W2120623005","https://openalex.org/W2121120744","https://openalex.org/W2126666513","https://openalex.org/W2167805334","https://openalex.org/W2243273878","https://openalex.org/W2269021429","https://openalex.org/W2281123640","https://openalex.org/W2344697123"],"related_works":["https://openalex.org/W2052372910","https://openalex.org/W2281123640","https://openalex.org/W2048549338","https://openalex.org/W2091597922","https://openalex.org/W2243273878","https://openalex.org/W2139579239","https://openalex.org/W2115120020","https://openalex.org/W2033635865","https://openalex.org/W2019776360","https://openalex.org/W4240794459"],"abstract_inverted_index":null,"counts_by_year":[{"year":2025,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-12T12:28:57.059296","created_date":"2016-06-24T00:00:00"}